A carregar...

Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records

INTRODUCTION: Preliminary data suggest that dipeptidyl peptidase-4 (DPP-4) inhibitors may reduce microvascular events, but there is a little evidence to support this from adequate real-world studies. This study aimed to compare microvascular outcomes between patients-prescribed vildagliptin and thos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Ther
Main Authors: Kolaczynski, Wlodzimierz M., Hankins, Matthew, Ong, Siew H., Richter, Hartmut, Clemens, Andreas, Toussi, Massoud
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014784/
https://ncbi.nlm.nih.gov/pubmed/27262995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0177-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!